CytoMed has generated the critical cell banks for the iPSC-derived hybrid of gamma delta T and Natural Killer cell technology and is currently undergoing process development into a potentially very ...
Welcome, ladies and gentlemen, to AstraZeneca's full-year and Q4 2024 results conference call for investors and analysts.
Inflation and tariffs will have the biggest impact on markets in 2025, followed by geopolitical tension, according to the ...
CytoMed Therapeutics Limited (NASDAQ: GDTC) ("CytoMed" or the "Company") today released a letter to shareholders from the Chairman of the Company's Board ...
Changing tastes among Asian palates is fuelling interest in wines from Japan, China, Thailand and India Read more at The ...
Abu Dhabi University (ADU) has signed a Memorandum of Understanding with Shanghai Stemstar Education Technology Co., Ltd., a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results